デフォルト表紙
市場調査レポート
商品コード
1514976

尿路疾患治療市場:治療別、用途別、エンドユーザー別、国別、地域別-産業分析、市場規模、市場シェア、2024年~2032年予測

Uropathy Treatment Market, By Treatment, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032


出版日
ページ情報
英文 264 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
尿路疾患治療市場:治療別、用途別、エンドユーザー別、国別、地域別-産業分析、市場規模、市場シェア、2024年~2032年予測
出版日: 2024年06月04日
発行: AnalystView Market Insights
ページ情報: 英文 264 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

尿路疾患治療市場規模は2023年に49億30万米ドルとなり、2024~2032年にかけてCAGR 4.90%で拡大

尿路疾患治療市場-市場力学

代替・補完療法と健康効果への関心の高まりが市場需要を促進する見込み

従来の医療に代わるものを求める人々の間で、代替・補完療法への関心が高まっています。ウロパシーはこのカテゴリーに属し、自然療法や健康へのホリスティックなアプローチを信じる人々にアピールします。こうした健康ニーズは、ウロパシー治療の需要を高めると予想されます。ウロパシーの利点は、皮膚状態の改善、消化器系の健康、全体的な健康など、さまざまな健康上の利点を主張しています。これらの主張は科学的に証明されているわけではないが、慢性疾患や健康維持のための代替治療を探している個人を惹きつけています。

心と体のつながりを考慮し、自然治癒法を重視するホリスティック・ヘルス・アプローチの動向は、より広範なウェルネス戦略の一環としてのウロパシーの魅力に貢献する可能性があります。さらに、泌尿器科治療は、医薬品やその他の医療介入と比較して低コストの治療オプションとして認識されています。このアクセシビリティは、手頃な医療の選択肢を求める人々の関心を高めることができます。

尿路疾患治療市場-主要洞察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間(2024~2032年)に約4.90%のCAGRで毎年成長すると推定されます。

治療別では、ステントとカテーテルへの高い需要により、装置セグメントが2023年に最大の市場シェアを示すと予測されました。

用途別セグメントでは、泌尿器科疾患治療のニーズが高いことから、泌尿器科セグメントが2023年の主要用途でした。

エンドユーザー別では、腎臓結石やその他の泌尿器科関連疾患の治療需要が高いことから、2023年には病院・クリニックがエンドユーザーのトップになりました。

地域別では、泌尿器科疾患の有病率の高さにより、アジア太平洋が2023年の主要収益源でした。

尿毒症治療市場-セグメンテーション分析:

尿路疾患治療の世界市場は、治療、用途、エンドユーザー、地域に基づいてセグメント化されます。

治療は装置と薬剤の2つに分類されます。装置セグメントが市場を独占しています。器具を用いた抗原、ウイルス試験に対する高い需要が市場の成長を促進しています。

用途別では、泌尿器セグメントと腎臓結石セグメントの2つに分類されます。泌尿器セグメントが市場を独占しています。子宮がん、膀胱結石などの泌尿器疾患の有病率の上昇が、同セグメントの需要を促進しています。

エンドユーザー別では、病院・クリニック、外来手術センター、その他に分類されます。病院・クリニックセグメントが市場を独占しており、予測期間中も高い優位性を維持すると予測されています。技術の進歩とともに、泌尿器疾患の診断治療がこのセグメントの成長に寄与しています。

尿路疾患治療市場-地理的洞察

泌尿器疾患治療市場は、北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。アジア太平洋が世界市場を独占しています。エビデンス別の医療と規制監督を重視する医療システムは、実質的な科学的エビデンスのない尿路疾患を受け入れにくい傾向にあります。さらに、アフリカ、南米、ラテンアメリカ一部を含む発展途上地域では、尿路疾患は低コストの代替療法または補完療法として存続している可能性があります。

尿路疾患治療市場-競合情勢:

尿路疾患治療市場には、多国籍企業と国内企業、ジェネリック医薬品メーカー、技術医薬品開発企業が混在しています。市場の主要企業は、パートナーシップの構築、M&A、研究開発への投資を行い、新しい泌尿器科治療機器やソリューションを革新しています。泌尿器科関連製品またはサービスの宣伝または販売に携わる企業は、各市場における代替医療や消費者向け健康製品を規制する枠組みをナビゲートします。

目次

第1章 尿路疾患治療市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブ概要

  • 市場内訳
  • 競合考察

第3章 尿路疾患治療の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 尿路疾患治療産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長展望マッピング
  • 規制枠組み分析

第5章 尿路疾患治療市場: COVID-19の影響分析

  • COVID-19前の影響分析
  • COVID-19後の影響分析

第6章 尿路疾患治療市場情勢

  • 尿路疾患治療市場シェア分析、2024年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 尿路疾患治療市場-治療別

  • 概要
    • 治療別セグメントシェア分析
    • 装置
    • 薬剤

第8章 尿路疾患治療市場-用途別

  • 概要
    • 用途別セグメントシェア分析
    • 泌尿器科
    • 腎臓結石

第9章 尿路疾患治療市場-エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 病院・クリニック
    • 外来手術センター
    • その他

第10章 尿路疾患治療市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析-尿路疾患治療業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Boston Scientific Corporation
    • Cook Medical
    • Bayer AG
    • Sanofi
    • B. Braun Melsungen AG
    • CR Bard, Inc.
    • Olympus Corporation
    • Teleflex Incorporated
    • Merit Medical Systems, Inc.
    • Johnson and Johnson
    • La Roche
    • Pfizer
    • Ureteral Stent Co.
    • Argon Medical Devices, Inc
    • その他

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Uropathy Treatment Market: Treatment Snapshot (2024)
  • TABLE Segment Dashboard; Definition and Scope, by Treatment
  • TABLE Global Uropathy Treatment Market, by Treatment 2019-2032 (USD Million)
  • TABLE Uropathy Treatment Market: Application Snapshot (2024)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Uropathy Treatment Market, by Application 2019-2032 (USD Million)
  • TABLE Uropathy Treatment Market: End User Snapshot (2024)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Uropathy Treatment Market, by End User 2019-2032 (USD Million)
  • TABLE Uropathy Treatment Market: Regional snapshot (2024)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Uropathy Treatment Market, by Region 2019-2032 (USD Million)
  • TABLE North America Uropathy Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Uropathy Treatment Market, by Treatment, 2019-2032 (USD Million)
  • TABLE North America Uropathy Treatment Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Uropathy Treatment Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Uropathy Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Uropathy Treatment Market, by Treatment, 2019-2032 (USD Million)
  • TABLE Europe Uropathy Treatment Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Uropathy Treatment Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Uropathy Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Uropathy Treatment Market, by Treatment, 2019-2032 (USD Million)
  • TABLE Asia Pacific Uropathy Treatment Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Uropathy Treatment Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Uropathy Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Uropathy Treatment Market, by Treatment, 2019-2032 (USD Million)
  • TABLE Latin America Uropathy Treatment Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Uropathy Treatment Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Uropathy Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Uropathy Treatment Market, by Treatment, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Uropathy Treatment Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Uropathy Treatment Market, by End User, 2019-2032 (USD Million)

List of Figures

  • FIGURE Uropathy Treatment Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2024
  • FIGURE Treatment segment market share analysis, 2024 & 2032
  • FIGURE Treatment segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2024 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End User segment market share analysis, 2024 & 2032
  • FIGURE End User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2024 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Uropathy Treatment Market share and leading players, 2024
  • FIGURE Europe Uropathy Treatment Market share and leading players, 2024
  • FIGURE Asia Pacific Uropathy Treatment Market share and leading players, 2024
  • FIGURE Latin America Uropathy Treatment Market share and leading players, 2024
  • FIGURE Middle East and Africa Uropathy Treatment Market share and leading players, 2024
  • FIGURE North America market share analysis by country, 2024
  • FIGURE U.S. Uropathy Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Uropathy Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Uropathy Treatment Market share analysis by country, 2024
  • FIGURE Germany Uropathy Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Uropathy Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Uropathy Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Uropathy Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Uropathy Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Uropathy Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Uropathy Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Uropathy Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Uropathy Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Uropathy Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Uropathy Treatment Market share analysis by country, 2024
  • FIGURE India Uropathy Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Uropathy Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Uropathy Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Uropathy Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Uropathy Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Uropathy Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Uropathy Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philipines Uropathy Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Uropathy Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Uropathy Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Uropathy Treatment Market share analysis by country, 2024
  • FIGURE Brazil Uropathy Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Uropathy Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Uropathy Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Uropathy Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Uropathy Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Uropathy Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Uropathy Treatment Market share analysis by country, 2024
  • FIGURE Saudi Arabia Uropathy Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Uropathy Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Uropathy Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Uropathy Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Uropathy Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Uropathy Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Uropathy Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
目次
Product Code: ANV3082

REPORT HIGHLIGHT

Uropathy Treatment Market size was valued at USD 4,900.30 Million in 2023, expanding at a CAGR of 4.90% from 2024 to 2032.

Uropathy, also known as urine therapy or urotherapy, is an alternative medical practice that involves using one's own urine as a therapeutic agent. It's rooted in the belief that urine contains substances that can help treat various ailments and promote overall health.

Uropathy Treatment Market- Market Dynamics

Growing interest in alternative and complementary therapies & health benefits are expected to propel market demand

The growing interest in alternative and complementary therapies among individuals seeking alternatives to conventional medicine. Uropathy falls into this category, appealing to those who believe in natural remedies and holistic approaches to health. These health needs are expected to enhance the demand for uropathy treatment. Benefits of uropathy claim various health benefits, such as improved skin conditions, digestive health, and overall wellness. These claims, while not scientifically proven, are attracting individuals looking for alternative treatments for chronic conditions or wellness maintenance.

The trend towards holistic health approaches that consider the mind-body connection and emphasize natural healing methods can contribute to the appeal of uropathy as part of a broader wellness strategy. Further, uropathy treatment is perceived as a low-cost treatment option compared to pharmaceuticals and other medical interventions. This accessibility can drive interest among those seeking affordable healthcare options.

Uropathy Treatment Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.90% over the forecast period (2024-2032)

Based on Treatment segmentation, devices segment was predicted to show maximum market share in the year 2023, owing to its high demand for stents and catheters.

Based on Application segmentation, the urology segment was the leading Application in 2023, due to the high need for treating urological disorders.

Based on End User segmentation, the hospitals & clinics segment was the leading End User in 2023, owing to high demand for the treatment of kidney stones, and other urology-related diseases.

On the basis of region, Asia Pacific was the leading revenue generator in 2023, owing to the high prevalence of urological diseases.

Uropathy Treatment Market- Segmentation Analysis:

The Global Uropathy Treatment Market is segmented on the basis of Treatment, Application, End User, and Region.

The market is divided into two categories based on Treatment: devices and drugs. The devices segment dominates the market. High demands for antigen, viruses test using instruments is promoting market growth.

The market is divided into two categories based on the Application: urology and kidney stone. The urology segment dominates the market. Rising prevalence of urologic disorders like uterine cancer, bladder stone are fueling segment demand.

The market is divided into three categories based on End User: hospitals & clinics, ambulatory surgical centers, and others. The hospitals & clinics segment dominates the market and is expected to maintain its high dominance during the forecast period. The diagnostic treatment for urological disease along with advancement in technologies is contributing to segment growth.

Uropathy Treatment Market- Geographical Insights

Worldwide, the Uropathy Treatment market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Asia Pacific dominates the global market. Healthcare systems with strong emphasis on evidence-based medicine and regulatory oversight tend to be less accepting of uropathy without substantial scientific evidence. Further, In developing regions, including parts of Africa, South Asia, and Latin America, uropathy may persist as a low-cost alternative or complementary therapy.

Uropathy Treatment Market- Competitive Landscape:

The Uropathy Treatment market includes a mix of multinational and domestic firms, generic drug manufacturers, and technology drug development companies. Major players in the market engage in formulating partnerships, mergers and acquisitions, and investing in research and development to innovate new urology treatment devices or solutions. Companies involved in promoting or selling uropathy-related products or services which navigate regulatory frameworks that govern alternative medicine and consumer health products in their respective markets.

Recent Developments:

In February 2023, Johnson & Johnson a subsidiary Ethicon announced the successful use of the MONARCH Platform for Urology to implement a robotic-assisted removal of kidney stones.

In May 2022, the Ureteral Stent Co. and the University Hospitals Cleveland's Dr. Lee received US FDA clearance for their collaboratively developed Relief Stent.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL UROPATHY TREATMENT MARKET KEY PLAYERS

  • Boston Scientific Corporation
  • Cook Medical
  • Bayer AG
  • Sanofi
  • B. Braun Melsungen AG
  • C. R. Bard, Inc.
  • Olympus Corporation
  • Teleflex Incorporated
  • Merit Medical Systems, Inc.
  • Johnson and Johnson
  • La Roche
  • Pfizer
  • Ureteral Stent Co.
  • Argon Medical Devices, Inc
  • Others

GLOBAL UROPATHY TREATMENT MARKET, BY TREATMENT- MARKET ANALYSIS, 2019-2032

  • Devices
  • Drugs

GLOBAL UROPATHY TREATMENT MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Urology
  • Kidney Stone

GLOBAL UROPATHY TREATMENT MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Hospitals & clinics
  • Ambulatory surgical centers
  • Others

GLOBAL UROPATHY TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Uropathy Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Uropathy Treatment Market Snippet by Treatment
    • 2.1.2. Uropathy Treatment Market Snippet by Application
    • 2.1.3. Uropathy Treatment Market Snippet by End User
    • 2.1.4. Uropathy Treatment Market Snippet by Country
    • 2.1.5. Uropathy Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Uropathy Treatment Key Market Trends

  • 3.1. Uropathy Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Uropathy Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Uropathy Treatment Market Opportunities
  • 3.4. Uropathy Treatment Market Future Trends

4. Uropathy Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Uropathy Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Uropathy Treatment Market Landscape

  • 6.1. Uropathy Treatment Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Uropathy Treatment Market - By Treatment

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Treatment, 2024 & 2032 (%)
    • 7.1.2. Devices
    • 7.1.3. Drugs

8. Uropathy Treatment Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Urology
    • 8.1.3. Kidney Stone

9. Uropathy Treatment Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospitals & clinics
    • 9.1.3. Ambulatory surgical centers
    • 9.1.4. Others

10. Uropathy Treatment Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Uropathy Treatment Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Uropathy Treatment Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Uropathy Treatment Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Uropathy Treatment Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Uropathy Treatment Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Uropathy Treatment Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Boston Scientific Corporation
    • 11.2.2. Cook Medical
    • 11.2.3. Bayer AG
    • 11.2.4. Sanofi
    • 11.2.5. B. Braun Melsungen AG
    • 11.2.6. C. R. Bard, Inc.
    • 11.2.7. Olympus Corporation
    • 11.2.8. Teleflex Incorporated
    • 11.2.9. Merit Medical Systems, Inc.
    • 11.2.10. Johnson and Johnson
    • 11.2.11. La Roche
    • 11.2.12. Pfizer
    • 11.2.13. Ureteral Stent Co.
    • 11.2.14. Argon Medical Devices, Inc
    • 11.2.15. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us